An assessment of Information disclosures by Pharmaceutical Industry: Evidence from India
The information disclosed by the companies in their annual reports reveals much about company’s performance and prospects. Investors take the information as base for decision for investment. Under such circumstance, companies choose to disclose beyond what is mandatorily required. Theories like agen...
Main Authors: | Rupali Khanna, Bhupinder Pal Singh Chahal |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad Politécnica de Valencia
2019-10-01
|
Series: | Multidisciplinary Journal for Education, Social and Technological Sciences |
Subjects: | |
Online Access: | https://polipapers.upv.es/index.php/MUSE/article/view/11531 |
Similar Items
-
Assessing the level of environmental information disclosure by listed companies on the stock market in Vietnam
by: Thi Kim Tuyen Nguyen, et al.
Published: (2019-08-01) -
Present and future of risk disclosure in Spanish non-financial listed companies
by: María Teresa Amezaga-Alonso, et al.
Published: (2020-01-01) -
VOLUNTARY INTERNET FINANCIAL REPORTING AND DISCLOSURE – A NEW CHALLENGE FOR ROMANIAN COMPANIES
by: Popa Dorina Nicoleta, et al.
Published: (2009-05-01) -
Pharmaceutical Industry Development in the Midst of Crisis: Global Trends
by: Z. A. Mamedyarov
Published: (2020-12-01) -
CURRENT TRENDS AND PROSPECTS OF THE RUSSIAN PHARMACEUTICAL INDUSTRY AND THE FOREIGN EXPERIENCE
by: Z. A. Mamedyarov
Published: (2018-01-01)